Investigating the efficacy of Angiotensin-converting enzyme inhibitors (ACEi) and Angiotensin receptor blockers (ARBs) as novel treatments for COVID-19

Project Member(s): Saunders, B., Hansbro, P., Faiz, A., Johansen, M.

Funding or Partner Organisation: Maridulu Budyari Gumal - The Sydney Partnership for Health, Education, Research and Enterprise (SPHERE) (Maridulu Budyari Gumal - The Sydney Partnership for Health, Education, Research and Enterprise)
Maridulu Budyari Gumal - The Sydney Partnership for Health, Education, Research and Enterprise (SPHERE) (Maridulu Budyari Gumal - The Sydney Partnership for Health, Education, Research and Enterprise)

Start year: 2020

FOR Codes: Health, Medical Infection Agents (incl. Prions), Microbiology, Basic Pharmacology, Basic pharmacology

Acknowledgement of Country

UTS acknowledges the Gadigal people of the Eora Nation, the Boorooberongal people of the Dharug Nation, the Bidiagal people and the Gamaygal people, upon whose ancestral lands our university stands. We would also like to pay respect to the Elders both past and present, acknowledging them as the traditional custodians of knowledge for these lands.